Globus Medical (GMED) news

Globus Medical announces acquisition of Higgs Boson Health to transform healthcare experience through AI-driven digital solutions

Globus Medical (NYSE: GMED) has announced the acquisition of Higgs Boson Health, a digital health company specializing in AI-driven platforms designed to enhance the healthcare experience for patients and providers. This strategic move aligns with Globus Medical’s broader initiative to integrate…

Globus Medical outlook FY adjusted EPS USD 4.95-5.05

Globus Medical has provided an updated outlook for fiscal year adjusted earnings per share (EPS), projecting a range of $4.95 to $5.05 [1]. This guidance reflects the company’s current financial expectations and incorporates anticipated performance across its business segments. The updated forecast…

Globus Medical outlook FY revenue USD 3,180-3,220 million

Globus Medical, Inc. (NYSE: GMED) has updated its financial outlook for fiscal year 2026, projecting revenue in the range of $3.18 billion to $3.22 billion, according to management guidance shared during its fourth-quarter and full-year 2025 earnings announcement. This represents an upward revision…

Globus Medical Inc: Stifel cuts target price to $80 from $95

Stifel recently adjusted its price target for Globus Medical Inc. (NYSE: GMED), reducing it to $80 from $95 while maintaining a Hold rating. This revision follows the firm’s earlier assessment of the company’s strong first-quarter 2026 performance, which included an earnings per share (EPS) of…

Profusa Inc: There can be no assurance regarding timing or outcome of GMed's assessment